Abstract
18F FDG-PET imaging is performed in cancer investigations to determine cancer localization, extent and metastasis. To assist accurate anatomical positioning of FDG uptake, all patients undergoing 18F-FDG PET scans also get a low-dose full body computed tomography (CT) scan. The presence of coronary artery calcification (CAC) can be detected on the CT scan; however, in the absence of reporting guidelines to direct differently, CAC is often overlooked and unreported. According to current guidelines, CAC testing provides an individualized measure of atherosclerotic burden that integrates an individual’s cumulative lifetime risk of coronary artery disease (CAD) and serves as part of a primary prevention strategy. We sought to determine the prevalence of CAC on 18F FDG-PET studies in a population of cancer patients and identify CAC reporting rates.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
